Cargando…
Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective
Tuberculosis (TB), one of the most prevalent infections, is on the rise today. Although there are drugs available in the market to combat this lethal disorder, there are several shortcomings with the current drug regimen, such as prolonged treatment period, drug resistance, high cost, etc. Hence, it...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057165/ https://www.ncbi.nlm.nih.gov/pubmed/35521286 http://dx.doi.org/10.1039/d0ra07398a |